COVID-19 Impact on Global Xerostomia Treatments Market Size, Status and Forecast 2020-2026
Dry mouth (xerostomia) refers to a condition in which the salivary glands in your mouth don't make enough saliva to keep your mouth wet.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Xerostomia Treatments market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Xerostomia Treatments industry.
Based on our recent survey, we have several different scenarios about the Xerostomia Treatments YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Xerostomia Treatments will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Xerostomia Treatments market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Xerostomia Treatments market in terms of revenue.
Players, stakeholders, and other participants in the global Xerostomia Treatments market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Xerostomia Treatments market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Xerostomia Treatments market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Xerostomia Treatments market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Xerostomia Treatments market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Xerostomia Treatments market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Xerostomia Treatments industry.
Based on our recent survey, we have several different scenarios about the Xerostomia Treatments YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Xerostomia Treatments will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Xerostomia Treatments market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Xerostomia Treatments market in terms of revenue.
Players, stakeholders, and other participants in the global Xerostomia Treatments market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Xerostomia Treatments market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Xerostomia Treatments market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Xerostomia Treatments market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Xerostomia Treatments market.
The following players are covered in this report:
- GlaxoSmithKline
- Church and Dwight
- Hikma Pharmaceuticals
- Pendopharm
- Parnell Pharmaceuticals
- Orahealth
- Salivary Stimulants
- Salivary Substitutes
- Dentifrices
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Xerostomia Treatments Revenue
1.4 Market Analysis by Type
1.4.1 Global Xerostomia Treatments Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Salivary Stimulants
1.4.3 Salivary Substitutes
1.4.4 Dentifrices
1.5 Market by Application
1.5.1 Global Xerostomia Treatments Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Xerostomia Treatments Industry Impact
1.6.1 How the Covid-19 is Affecting the Xerostomia Treatments Industry
1.6.1.1 Xerostomia Treatments Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Xerostomia Treatments Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Xerostomia Treatments Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Xerostomia Treatments Market Perspective (2015-2026)
2.2 Xerostomia Treatments Growth Trends by Regions
2.2.1 Xerostomia Treatments Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Xerostomia Treatments Historic Market Share by Regions (2015-2020)
2.2.3 Xerostomia Treatments Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Xerostomia Treatments Market Growth Strategy
2.3.6 Primary Interviews with Key Xerostomia Treatments Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Xerostomia Treatments Players by Market Size
3.1.1 Global Top Xerostomia Treatments Players by Revenue (2015-2020)
3.1.2 Global Xerostomia Treatments Revenue Market Share by Players (2015-2020)
3.1.3 Global Xerostomia Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Xerostomia Treatments Market Concentration Ratio
3.2.1 Global Xerostomia Treatments Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Xerostomia Treatments Revenue in 2019
3.3 Xerostomia Treatments Key Players Head office and Area Served
3.4 Key Players Xerostomia Treatments Product Solution and Service
3.5 Date of Enter into Xerostomia Treatments Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Xerostomia Treatments Historic Market Size by Type (2015-2020)
4.2 Global Xerostomia Treatments Forecasted Market Size by Type (2021-2026)
5 XEROSTOMIA TREATMENTS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Xerostomia Treatments Market Size by Application (2015-2020)
5.2 Global Xerostomia Treatments Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Xerostomia Treatments Market Size (2015-2020)
6.2 Xerostomia Treatments Key Players in North America (2019-2020)
6.3 North America Xerostomia Treatments Market Size by Type (2015-2020)
6.4 North America Xerostomia Treatments Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Xerostomia Treatments Market Size (2015-2020)
7.2 Xerostomia Treatments Key Players in Europe (2019-2020)
7.3 Europe Xerostomia Treatments Market Size by Type (2015-2020)
7.4 Europe Xerostomia Treatments Market Size by Application (2015-2020)
8 CHINA
8.1 China Xerostomia Treatments Market Size (2015-2020)
8.2 Xerostomia Treatments Key Players in China (2019-2020)
8.3 China Xerostomia Treatments Market Size by Type (2015-2020)
8.4 China Xerostomia Treatments Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Xerostomia Treatments Market Size (2015-2020)
9.2 Xerostomia Treatments Key Players in Japan (2019-2020)
9.3 Japan Xerostomia Treatments Market Size by Type (2015-2020)
9.4 Japan Xerostomia Treatments Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Xerostomia Treatments Market Size (2015-2020)
10.2 Xerostomia Treatments Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Xerostomia Treatments Market Size by Type (2015-2020)
10.4 Southeast Asia Xerostomia Treatments Market Size by Application (2015-2020)
11 INDIA
11.1 India Xerostomia Treatments Market Size (2015-2020)
11.2 Xerostomia Treatments Key Players in India (2019-2020)
11.3 India Xerostomia Treatments Market Size by Type (2015-2020)
11.4 India Xerostomia Treatments Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Xerostomia Treatments Market Size (2015-2020)
12.2 Xerostomia Treatments Key Players in Central & South America (2019-2020)
12.3 Central & South America Xerostomia Treatments Market Size by Type (2015-2020)
12.4 Central & South America Xerostomia Treatments Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.1.3 GlaxoSmithKline Xerostomia Treatments Introduction
13.1.4 GlaxoSmithKline Revenue in Xerostomia Treatments Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Church and Dwight
13.2.1 Church and Dwight Company Details
13.2.2 Church and Dwight Business Overview and Its Total Revenue
13.2.3 Church and Dwight Xerostomia Treatments Introduction
13.2.4 Church and Dwight Revenue in Xerostomia Treatments Business (2015-2020)
13.2.5 Church and Dwight Recent Development
13.3 Hikma Pharmaceuticals
13.3.1 Hikma Pharmaceuticals Company Details
13.3.2 Hikma Pharmaceuticals Business Overview and Its Total Revenue
13.3.3 Hikma Pharmaceuticals Xerostomia Treatments Introduction
13.3.4 Hikma Pharmaceuticals Revenue in Xerostomia Treatments Business (2015-2020)
13.3.5 Hikma Pharmaceuticals Recent Development
13.4 Pendopharm
13.4.1 Pendopharm Company Details
13.4.2 Pendopharm Business Overview and Its Total Revenue
13.4.3 Pendopharm Xerostomia Treatments Introduction
13.4.4 Pendopharm Revenue in Xerostomia Treatments Business (2015-2020)
13.4.5 Pendopharm Recent Development
13.5 Parnell Pharmaceuticals
13.5.1 Parnell Pharmaceuticals Company Details
13.5.2 Parnell Pharmaceuticals Business Overview and Its Total Revenue
13.5.3 Parnell Pharmaceuticals Xerostomia Treatments Introduction
13.5.4 Parnell Pharmaceuticals Revenue in Xerostomia Treatments Business (2015-2020)
13.5.5 Parnell Pharmaceuticals Recent Development
13.6 Orahealth
13.6.1 Orahealth Company Details
13.6.2 Orahealth Business Overview and Its Total Revenue
13.6.3 Orahealth Xerostomia Treatments Introduction
13.6.4 Orahealth Revenue in Xerostomia Treatments Business (2015-2020)
13.6.5 Orahealth Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Xerostomia Treatments Revenue
1.4 Market Analysis by Type
1.4.1 Global Xerostomia Treatments Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Salivary Stimulants
1.4.3 Salivary Substitutes
1.4.4 Dentifrices
1.5 Market by Application
1.5.1 Global Xerostomia Treatments Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Coronavirus Disease 2019 (Covid-19): Xerostomia Treatments Industry Impact
1.6.1 How the Covid-19 is Affecting the Xerostomia Treatments Industry
1.6.1.1 Xerostomia Treatments Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Xerostomia Treatments Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Xerostomia Treatments Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Xerostomia Treatments Market Perspective (2015-2026)
2.2 Xerostomia Treatments Growth Trends by Regions
2.2.1 Xerostomia Treatments Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Xerostomia Treatments Historic Market Share by Regions (2015-2020)
2.2.3 Xerostomia Treatments Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Xerostomia Treatments Market Growth Strategy
2.3.6 Primary Interviews with Key Xerostomia Treatments Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Xerostomia Treatments Players by Market Size
3.1.1 Global Top Xerostomia Treatments Players by Revenue (2015-2020)
3.1.2 Global Xerostomia Treatments Revenue Market Share by Players (2015-2020)
3.1.3 Global Xerostomia Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Xerostomia Treatments Market Concentration Ratio
3.2.1 Global Xerostomia Treatments Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Xerostomia Treatments Revenue in 2019
3.3 Xerostomia Treatments Key Players Head office and Area Served
3.4 Key Players Xerostomia Treatments Product Solution and Service
3.5 Date of Enter into Xerostomia Treatments Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Xerostomia Treatments Historic Market Size by Type (2015-2020)
4.2 Global Xerostomia Treatments Forecasted Market Size by Type (2021-2026)
5 XEROSTOMIA TREATMENTS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Xerostomia Treatments Market Size by Application (2015-2020)
5.2 Global Xerostomia Treatments Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Xerostomia Treatments Market Size (2015-2020)
6.2 Xerostomia Treatments Key Players in North America (2019-2020)
6.3 North America Xerostomia Treatments Market Size by Type (2015-2020)
6.4 North America Xerostomia Treatments Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Xerostomia Treatments Market Size (2015-2020)
7.2 Xerostomia Treatments Key Players in Europe (2019-2020)
7.3 Europe Xerostomia Treatments Market Size by Type (2015-2020)
7.4 Europe Xerostomia Treatments Market Size by Application (2015-2020)
8 CHINA
8.1 China Xerostomia Treatments Market Size (2015-2020)
8.2 Xerostomia Treatments Key Players in China (2019-2020)
8.3 China Xerostomia Treatments Market Size by Type (2015-2020)
8.4 China Xerostomia Treatments Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Xerostomia Treatments Market Size (2015-2020)
9.2 Xerostomia Treatments Key Players in Japan (2019-2020)
9.3 Japan Xerostomia Treatments Market Size by Type (2015-2020)
9.4 Japan Xerostomia Treatments Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Xerostomia Treatments Market Size (2015-2020)
10.2 Xerostomia Treatments Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Xerostomia Treatments Market Size by Type (2015-2020)
10.4 Southeast Asia Xerostomia Treatments Market Size by Application (2015-2020)
11 INDIA
11.1 India Xerostomia Treatments Market Size (2015-2020)
11.2 Xerostomia Treatments Key Players in India (2019-2020)
11.3 India Xerostomia Treatments Market Size by Type (2015-2020)
11.4 India Xerostomia Treatments Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Xerostomia Treatments Market Size (2015-2020)
12.2 Xerostomia Treatments Key Players in Central & South America (2019-2020)
12.3 Central & South America Xerostomia Treatments Market Size by Type (2015-2020)
12.4 Central & South America Xerostomia Treatments Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Details
13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.1.3 GlaxoSmithKline Xerostomia Treatments Introduction
13.1.4 GlaxoSmithKline Revenue in Xerostomia Treatments Business (2015-2020))
13.1.5 GlaxoSmithKline Recent Development
13.2 Church and Dwight
13.2.1 Church and Dwight Company Details
13.2.2 Church and Dwight Business Overview and Its Total Revenue
13.2.3 Church and Dwight Xerostomia Treatments Introduction
13.2.4 Church and Dwight Revenue in Xerostomia Treatments Business (2015-2020)
13.2.5 Church and Dwight Recent Development
13.3 Hikma Pharmaceuticals
13.3.1 Hikma Pharmaceuticals Company Details
13.3.2 Hikma Pharmaceuticals Business Overview and Its Total Revenue
13.3.3 Hikma Pharmaceuticals Xerostomia Treatments Introduction
13.3.4 Hikma Pharmaceuticals Revenue in Xerostomia Treatments Business (2015-2020)
13.3.5 Hikma Pharmaceuticals Recent Development
13.4 Pendopharm
13.4.1 Pendopharm Company Details
13.4.2 Pendopharm Business Overview and Its Total Revenue
13.4.3 Pendopharm Xerostomia Treatments Introduction
13.4.4 Pendopharm Revenue in Xerostomia Treatments Business (2015-2020)
13.4.5 Pendopharm Recent Development
13.5 Parnell Pharmaceuticals
13.5.1 Parnell Pharmaceuticals Company Details
13.5.2 Parnell Pharmaceuticals Business Overview and Its Total Revenue
13.5.3 Parnell Pharmaceuticals Xerostomia Treatments Introduction
13.5.4 Parnell Pharmaceuticals Revenue in Xerostomia Treatments Business (2015-2020)
13.5.5 Parnell Pharmaceuticals Recent Development
13.6 Orahealth
13.6.1 Orahealth Company Details
13.6.2 Orahealth Business Overview and Its Total Revenue
13.6.3 Orahealth Xerostomia Treatments Introduction
13.6.4 Orahealth Revenue in Xerostomia Treatments Business (2015-2020)
13.6.5 Orahealth Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Xerostomia Treatments Key Market Segments
Table 2. Key Players Covered: Ranking by Xerostomia Treatments Revenue
Table 3. Ranking of Global Top Xerostomia Treatments Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Xerostomia Treatments Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Salivary Stimulants
Table 6. Key Players of Salivary Substitutes
Table 7. Key Players of Dentifrices
Table 8. COVID-19 Impact Global Market: (Four Xerostomia Treatments Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Xerostomia Treatments Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Xerostomia Treatments Players to Combat Covid-19 Impact
Table 13. Global Xerostomia Treatments Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Xerostomia Treatments Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Xerostomia Treatments Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Xerostomia Treatments Market Share by Regions (2015-2020)
Table 17. Global Xerostomia Treatments Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Xerostomia Treatments Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Xerostomia Treatments Market Growth Strategy
Table 23. Main Points Interviewed from Key Xerostomia Treatments Players
Table 24. Global Xerostomia Treatments Revenue by Players (2015-2020) (Million US$)
Table 25. Global Xerostomia Treatments Market Share by Players (2015-2020)
Table 26. Global Top Xerostomia Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Xerostomia Treatments as of 2019)
Table 27. Global Xerostomia Treatments by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Xerostomia Treatments Product Solution and Service
Table 30. Date of Enter into Xerostomia Treatments Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Xerostomia Treatments Market Size by Type (2015-2020) (Million US$)
Table 33. Global Xerostomia Treatments Market Size Share by Type (2015-2020)
Table 34. Global Xerostomia Treatments Revenue Market Share by Type (2021-2026)
Table 35. Global Xerostomia Treatments Market Size Share by Application (2015-2020)
Table 36. Global Xerostomia Treatments Market Size by Application (2015-2020) (Million US$)
Table 37. Global Xerostomia Treatments Market Size Share by Application (2021-2026)
Table 38. North America Key Players Xerostomia Treatments Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Xerostomia Treatments Market Share (2019-2020)
Table 40. North America Xerostomia Treatments Market Size by Type (2015-2020) (Million US$)
Table 41. North America Xerostomia Treatments Market Share by Type (2015-2020)
Table 42. North America Xerostomia Treatments Market Size by Application (2015-2020) (Million US$)
Table 43. North America Xerostomia Treatments Market Share by Application (2015-2020)
Table 44. Europe Key Players Xerostomia Treatments Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Xerostomia Treatments Market Share (2019-2020)
Table 46. Europe Xerostomia Treatments Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Xerostomia Treatments Market Share by Type (2015-2020)
Table 48. Europe Xerostomia Treatments Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Xerostomia Treatments Market Share by Application (2015-2020)
Table 50. China Key Players Xerostomia Treatments Revenue (2019-2020) (Million US$)
Table 51. China Key Players Xerostomia Treatments Market Share (2019-2020)
Table 52. China Xerostomia Treatments Market Size by Type (2015-2020) (Million US$)
Table 53. China Xerostomia Treatments Market Share by Type (2015-2020)
Table 54. China Xerostomia Treatments Market Size by Application (2015-2020) (Million US$)
Table 55. China Xerostomia Treatments Market Share by Application (2015-2020)
Table 56. Japan Key Players Xerostomia Treatments Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Xerostomia Treatments Market Share (2019-2020)
Table 58. Japan Xerostomia Treatments Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Xerostomia Treatments Market Share by Type (2015-2020)
Table 60. Japan Xerostomia Treatments Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Xerostomia Treatments Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Xerostomia Treatments Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Xerostomia Treatments Market Share (2019-2020)
Table 64. Southeast Asia Xerostomia Treatments Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Xerostomia Treatments Market Share by Type (2015-2020)
Table 66. Southeast Asia Xerostomia Treatments Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Xerostomia Treatments Market Share by Application (2015-2020)
Table 68. India Key Players Xerostomia Treatments Revenue (2019-2020) (Million US$)
Table 69. India Key Players Xerostomia Treatments Market Share (2019-2020)
Table 70. India Xerostomia Treatments Market Size by Type (2015-2020) (Million US$)
Table 71. India Xerostomia Treatments Market Share by Type (2015-2020)
Table 72. India Xerostomia Treatments Market Size by Application (2015-2020) (Million US$)
Table 73. India Xerostomia Treatments Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Xerostomia Treatments Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Xerostomia Treatments Market Share (2019-2020)
Table 76. Central & South America Xerostomia Treatments Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Xerostomia Treatments Market Share by Type (2015-2020)
Table 78. Central & South America Xerostomia Treatments Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Xerostomia Treatments Market Share by Application (2015-2020)
Table 80. GlaxoSmithKline Company Details
Table 81. GlaxoSmithKline Business Overview
Table 82. GlaxoSmithKline Product
Table 83. GlaxoSmithKline Revenue in Xerostomia Treatments Business (2015-2020) (Million US$)
Table 84. GlaxoSmithKline Recent Development
Table 85. Church and Dwight Company Details
Table 86. Church and Dwight Business Overview
Table 87. Church and Dwight Product
Table 88. Church and Dwight Revenue in Xerostomia Treatments Business (2015-2020) (Million US$)
Table 89. Church and Dwight Recent Development
Table 90. Hikma Pharmaceuticals Company Details
Table 91. Hikma Pharmaceuticals Business Overview
Table 92. Hikma Pharmaceuticals Product
Table 93. Hikma Pharmaceuticals Revenue in Xerostomia Treatments Business (2015-2020) (Million US$)
Table 94. Hikma Pharmaceuticals Recent Development
Table 95. Pendopharm Company Details
Table 96. Pendopharm Business Overview
Table 97. Pendopharm Product
Table 98. Pendopharm Revenue in Xerostomia Treatments Business (2015-2020) (Million US$)
Table 99. Pendopharm Recent Development
Table 100. Parnell Pharmaceuticals Company Details
Table 101. Parnell Pharmaceuticals Business Overview
Table 102. Parnell Pharmaceuticals Product
Table 103. Parnell Pharmaceuticals Revenue in Xerostomia Treatments Business (2015-2020) (Million US$)
Table 104. Parnell Pharmaceuticals Recent Development
Table 105. Orahealth Company Details
Table 106. Orahealth Business Overview
Table 107. Orahealth Product
Table 108. Orahealth Revenue in Xerostomia Treatments Business (2015-2020) (Million US$)
Table 109. Orahealth Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 1. Xerostomia Treatments Key Market Segments
Table 2. Key Players Covered: Ranking by Xerostomia Treatments Revenue
Table 3. Ranking of Global Top Xerostomia Treatments Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Xerostomia Treatments Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Salivary Stimulants
Table 6. Key Players of Salivary Substitutes
Table 7. Key Players of Dentifrices
Table 8. COVID-19 Impact Global Market: (Four Xerostomia Treatments Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Xerostomia Treatments Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Xerostomia Treatments Players to Combat Covid-19 Impact
Table 13. Global Xerostomia Treatments Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Xerostomia Treatments Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Xerostomia Treatments Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Xerostomia Treatments Market Share by Regions (2015-2020)
Table 17. Global Xerostomia Treatments Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Xerostomia Treatments Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Xerostomia Treatments Market Growth Strategy
Table 23. Main Points Interviewed from Key Xerostomia Treatments Players
Table 24. Global Xerostomia Treatments Revenue by Players (2015-2020) (Million US$)
Table 25. Global Xerostomia Treatments Market Share by Players (2015-2020)
Table 26. Global Top Xerostomia Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Xerostomia Treatments as of 2019)
Table 27. Global Xerostomia Treatments by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Xerostomia Treatments Product Solution and Service
Table 30. Date of Enter into Xerostomia Treatments Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Xerostomia Treatments Market Size by Type (2015-2020) (Million US$)
Table 33. Global Xerostomia Treatments Market Size Share by Type (2015-2020)
Table 34. Global Xerostomia Treatments Revenue Market Share by Type (2021-2026)
Table 35. Global Xerostomia Treatments Market Size Share by Application (2015-2020)
Table 36. Global Xerostomia Treatments Market Size by Application (2015-2020) (Million US$)
Table 37. Global Xerostomia Treatments Market Size Share by Application (2021-2026)
Table 38. North America Key Players Xerostomia Treatments Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Xerostomia Treatments Market Share (2019-2020)
Table 40. North America Xerostomia Treatments Market Size by Type (2015-2020) (Million US$)
Table 41. North America Xerostomia Treatments Market Share by Type (2015-2020)
Table 42. North America Xerostomia Treatments Market Size by Application (2015-2020) (Million US$)
Table 43. North America Xerostomia Treatments Market Share by Application (2015-2020)
Table 44. Europe Key Players Xerostomia Treatments Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Xerostomia Treatments Market Share (2019-2020)
Table 46. Europe Xerostomia Treatments Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Xerostomia Treatments Market Share by Type (2015-2020)
Table 48. Europe Xerostomia Treatments Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Xerostomia Treatments Market Share by Application (2015-2020)
Table 50. China Key Players Xerostomia Treatments Revenue (2019-2020) (Million US$)
Table 51. China Key Players Xerostomia Treatments Market Share (2019-2020)
Table 52. China Xerostomia Treatments Market Size by Type (2015-2020) (Million US$)
Table 53. China Xerostomia Treatments Market Share by Type (2015-2020)
Table 54. China Xerostomia Treatments Market Size by Application (2015-2020) (Million US$)
Table 55. China Xerostomia Treatments Market Share by Application (2015-2020)
Table 56. Japan Key Players Xerostomia Treatments Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Xerostomia Treatments Market Share (2019-2020)
Table 58. Japan Xerostomia Treatments Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Xerostomia Treatments Market Share by Type (2015-2020)
Table 60. Japan Xerostomia Treatments Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Xerostomia Treatments Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Xerostomia Treatments Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Xerostomia Treatments Market Share (2019-2020)
Table 64. Southeast Asia Xerostomia Treatments Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Xerostomia Treatments Market Share by Type (2015-2020)
Table 66. Southeast Asia Xerostomia Treatments Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Xerostomia Treatments Market Share by Application (2015-2020)
Table 68. India Key Players Xerostomia Treatments Revenue (2019-2020) (Million US$)
Table 69. India Key Players Xerostomia Treatments Market Share (2019-2020)
Table 70. India Xerostomia Treatments Market Size by Type (2015-2020) (Million US$)
Table 71. India Xerostomia Treatments Market Share by Type (2015-2020)
Table 72. India Xerostomia Treatments Market Size by Application (2015-2020) (Million US$)
Table 73. India Xerostomia Treatments Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Xerostomia Treatments Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Xerostomia Treatments Market Share (2019-2020)
Table 76. Central & South America Xerostomia Treatments Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Xerostomia Treatments Market Share by Type (2015-2020)
Table 78. Central & South America Xerostomia Treatments Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Xerostomia Treatments Market Share by Application (2015-2020)
Table 80. GlaxoSmithKline Company Details
Table 81. GlaxoSmithKline Business Overview
Table 82. GlaxoSmithKline Product
Table 83. GlaxoSmithKline Revenue in Xerostomia Treatments Business (2015-2020) (Million US$)
Table 84. GlaxoSmithKline Recent Development
Table 85. Church and Dwight Company Details
Table 86. Church and Dwight Business Overview
Table 87. Church and Dwight Product
Table 88. Church and Dwight Revenue in Xerostomia Treatments Business (2015-2020) (Million US$)
Table 89. Church and Dwight Recent Development
Table 90. Hikma Pharmaceuticals Company Details
Table 91. Hikma Pharmaceuticals Business Overview
Table 92. Hikma Pharmaceuticals Product
Table 93. Hikma Pharmaceuticals Revenue in Xerostomia Treatments Business (2015-2020) (Million US$)
Table 94. Hikma Pharmaceuticals Recent Development
Table 95. Pendopharm Company Details
Table 96. Pendopharm Business Overview
Table 97. Pendopharm Product
Table 98. Pendopharm Revenue in Xerostomia Treatments Business (2015-2020) (Million US$)
Table 99. Pendopharm Recent Development
Table 100. Parnell Pharmaceuticals Company Details
Table 101. Parnell Pharmaceuticals Business Overview
Table 102. Parnell Pharmaceuticals Product
Table 103. Parnell Pharmaceuticals Revenue in Xerostomia Treatments Business (2015-2020) (Million US$)
Table 104. Parnell Pharmaceuticals Recent Development
Table 105. Orahealth Company Details
Table 106. Orahealth Business Overview
Table 107. Orahealth Product
Table 108. Orahealth Revenue in Xerostomia Treatments Business (2015-2020) (Million US$)
Table 109. Orahealth Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Xerostomia Treatments Market Share by Type: 2020 VS 2026
Figure 2. Salivary Stimulants Features
Figure 3. Salivary Substitutes Features
Figure 4. Dentifrices Features
Figure 5. Global Xerostomia Treatments Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Xerostomia Treatments Report Years Considered
Figure 10. Global Xerostomia Treatments Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Xerostomia Treatments Market Share by Regions: 2020 VS 2026
Figure 12. Global Xerostomia Treatments Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Xerostomia Treatments Market Share by Players in 2019
Figure 15. Global Top Xerostomia Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Xerostomia Treatments as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Xerostomia Treatments Revenue in 2019
Figure 17. North America Xerostomia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Xerostomia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Xerostomia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Xerostomia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Xerostomia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Xerostomia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Xerostomia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. GlaxoSmithKline Revenue Growth Rate in Xerostomia Treatments Business (2015-2020)
Figure 26. Church and Dwight Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Church and Dwight Revenue Growth Rate in Xerostomia Treatments Business (2015-2020)
Figure 28. Hikma Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Hikma Pharmaceuticals Revenue Growth Rate in Xerostomia Treatments Business (2015-2020)
Figure 30. Pendopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Pendopharm Revenue Growth Rate in Xerostomia Treatments Business (2015-2020)
Figure 32. Parnell Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Parnell Pharmaceuticals Revenue Growth Rate in Xerostomia Treatments Business (2015-2020)
Figure 34. Orahealth Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Orahealth Revenue Growth Rate in Xerostomia Treatments Business (2015-2020)
Figure 36. Bottom-up and Top-down Approaches for This Report
Figure 37. Data Triangulation
Figure 38. Key Executives Interviewed
Figure 1. Global Xerostomia Treatments Market Share by Type: 2020 VS 2026
Figure 2. Salivary Stimulants Features
Figure 3. Salivary Substitutes Features
Figure 4. Dentifrices Features
Figure 5. Global Xerostomia Treatments Market Share by Application: 2020 VS 2026
Figure 6. Hospital Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Xerostomia Treatments Report Years Considered
Figure 10. Global Xerostomia Treatments Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Xerostomia Treatments Market Share by Regions: 2020 VS 2026
Figure 12. Global Xerostomia Treatments Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Xerostomia Treatments Market Share by Players in 2019
Figure 15. Global Top Xerostomia Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Xerostomia Treatments as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Xerostomia Treatments Revenue in 2019
Figure 17. North America Xerostomia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Xerostomia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Xerostomia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Xerostomia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Xerostomia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Xerostomia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Xerostomia Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. GlaxoSmithKline Revenue Growth Rate in Xerostomia Treatments Business (2015-2020)
Figure 26. Church and Dwight Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Church and Dwight Revenue Growth Rate in Xerostomia Treatments Business (2015-2020)
Figure 28. Hikma Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Hikma Pharmaceuticals Revenue Growth Rate in Xerostomia Treatments Business (2015-2020)
Figure 30. Pendopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Pendopharm Revenue Growth Rate in Xerostomia Treatments Business (2015-2020)
Figure 32. Parnell Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Parnell Pharmaceuticals Revenue Growth Rate in Xerostomia Treatments Business (2015-2020)
Figure 34. Orahealth Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Orahealth Revenue Growth Rate in Xerostomia Treatments Business (2015-2020)
Figure 36. Bottom-up and Top-down Approaches for This Report
Figure 37. Data Triangulation
Figure 38. Key Executives Interviewed
